CLINICAL ROLE -
FCRL5-Directed CAR T-Cell Therapy: A Novel Therapeutic Approach for Multiple Myeloma
CAR T-cells specifically targeting FCRL5, when integrated with IL-15, may improve cytotoxicity, thereby enhancing the therapeutic potency of these cells.
Read More
Genomic Analysis May Improve Treatment Strategies for Therapy-Resistant Melanoma
Precision therapies, although effective in earlier stages, may not work later.